citalopram and pindolol

citalopram has been researched along with pindolol in 26 studies

Research

Studies (26)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (19.23)	18.2507
2000's	12 (46.15)	29.6817
2010's	9 (34.62)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carrupt, PA; Gaillard, P; Schambel, P; Testa, B	1
Topliss, JG; Yoshida, F	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Lombardo, F; Obach, RS; Waters, NJ	1
Ahman, M; Holmén, AG; Wan, H	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Hietala, J; Kuoppamäki, M; Laakso, A; Pälvimäki, EP; Syvälahti, E	1
Auerbach, SB; Hjorth, S	1
Hjorth, S; Sharp, T	1
Hjorth, S	1
Ahlenius, S; Arborelius, L; Linnér, L; Svensson, TH; Wallsten, C	1
Ase, AR; Descarries, L; Hen, R; Reader, TA; Riad, M	1
Adams, KH; Hasselbalch, SG; Holm, S; Knudsen, GM; Kristiansen, H; Paulson, OB; Pinborg, LH; Yndgaard, S	1
Croft, RJ; Illic, S; Nathan, PJ; Phan, KL; Segrave, R	1
Kuypers, KP; Ramaekers, JG; Wingen, M	2
Alvarez, E; de Diego-Adeliño, J; Pérez, V; Pérez-Egea, R; Portella, MJ; Puigdemont, D	1
Álvarez, E; Artigas, F; Ballesteros, J; de Diego-Adeliño, J; Oller, S; Pérez, V; Portella, MJ; Puigdemont, D; Santos, B	1
Terao, T	1

Reviews

2 review(s) available for citalopram and pindolol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:7 Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Personality Inventory; Pindolol; Psychometrics; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Time Factors; Treatment Outcome	2011

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression.

The Journal of clinical psychiatry, 2011, Volume: 72, Issue:7

Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Personality Inventory; Pindolol; Psychometrics; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Time Factors; Treatment Outcome

2011

Trials

4 trial(s) available for citalopram and pindolol

Article	Year
Selective verbal and spatial memory impairment after 5-HT1A and 5-HT2A receptor blockade in healthy volunteers pre-treated with an SSRI. Journal of psychopharmacology (Oxford, England), 2007, Volume: 21, Issue:5 Topics: Administration, Oral; Adult; Affect; Brain; Citalopram; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Ketanserin; Male; Mental Recall; Pindolol; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Reference Values; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Space Perception; Verbal Learning	2007
The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers. Psychopharmacology, 2007, Volume: 190, Issue:3 Topics: Administration, Oral; Adult; Attention; Citalopram; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Ketanserin; Male; Pindolol; Psychomotor Performance; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sleep	2007
A short duration of untreated illness (DUI) improves response outcomes in first-depressive episodes. Journal of affective disorders, 2010, Volume: 120, Issue:1-3 Topics: Adult; Citalopram; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluoxetine; Humans; Male; Pindolol; Recurrence; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists	2010
Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:7 Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Personality Inventory; Pindolol; Psychometrics; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Time Factors; Treatment Outcome	2011

Other Studies

21 other study(ies) available for citalopram and pindolol

Article	Year
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models. Journal of medicinal chemistry, 1996, Jan-05, Volume: 39, Issue:1 Topics: Indoles; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Piperazines; Propanolamines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes	1996
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Up-regulation of beta 1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments. Psychopharmacology, 1994, Volume: 115, Issue:4 Topics: Adrenergic beta-1 Receptor Agonists; Animals; Autoradiography; Brain Chemistry; Citalopram; Fluoxetine; Image Processing, Computer-Assisted; Imipramine; Iodocyanopindolol; Male; Pindolol; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Up-Regulation	1994
Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors. European journal of pharmacology, 1994, Aug-01, Volume: 260, Issue:2-3 Topics: Analysis of Variance; Animals; Antidepressive Agents; Autoreceptors; Citalopram; Hippocampus; Male; Microdialysis; Paroxetine; Pindolol; Piperazines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Stereoisomerism	1994
In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:2 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Animals; Citalopram; Dialysis; Hippocampus; Male; Metoprolol; Penbutolol; Perfusion; Pindolol; Propanolamines; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Stereoisomerism	1993
(-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine. European journal of pharmacology, 1996, May-15, Volume: 303, Issue:3 Topics: Animals; Buspirone; Citalopram; Drug Synergism; Hippocampus; Male; Pindolol; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists	1996
Partial 5-HT1A receptor agonist properties of (-)pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo. Psychopharmacology, 2000, Volume: 151, Issue:1 Topics: Animals; Citalopram; Drug Interactions; Electrophysiology; Male; Pindolol; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists	2000
Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout. Journal of neurochemistry, 2001, Volume: 78, Issue:3 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Autoradiography; Behavior, Animal; Brain; Carrier Proteins; Citalopram; Female; Immunohistochemistry; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Knockout; Nerve Tissue Proteins; Neurons; Pindolol; Radioligand Assay; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists	2001
[18F]altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2004, Volume: 24, Issue:9 Topics: Adrenergic beta-Antagonists; Adult; Brain; Citalopram; Female; Fluorine Radioisotopes; Humans; Ketanserin; Male; Pindolol; Prolactin; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed	2004
Pindolol does not augment central serotonin function increases to citalopram in humans: an auditory evoked potential investigation. Pharmacology, biochemistry, and behavior, 2006, Volume: 85, Issue:1 Topics: Adult; Citalopram; Double-Blind Method; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Male; Pindolol; Placebos; Serotonin	2006
Can pindolol really enhance antidepressant effect? The Journal of clinical psychiatry, 2011, Volume: 72, Issue:11 Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; Female; Humans; Male; Pindolol; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists	2011